Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study

Affiliations

¹ Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi, Tokyo, 173-8610, Japan. terui.tadashi@nihon-u.ac.jp.
² Tokyo Medical University, Tokyo, Japan.
³ Seibo International Catholic Hospital, Tokyo, Japan.
⁴ Kochi Medical School, Kochi University, Kochi, Japan.
⁵ Nagoya City University, Nagoya, Japan.
⁶ Fukuoka University, Fukuoka, Japan.
⁷ Teikyo University, Tokyo, Japan.
⁸ Sapporo Skin Clinic, Sapporo, Japan.
⁹ Amgen K.K., Tokyo, Japan.
¹⁰ Amgen Inc., Thousand Oaks, CA, USA.
¹¹ Ehime University Graduate School of Medicine, Ehime, Japan.

Published Erratum

Tadashi Terui et al. Am J Clin Dermatol. 2024 Jan.

. 2024 Jan;25(1):165-167.

doi: 10.1007/s40257-023-00825-0.

¹ Nihon University School of Medicine, 30-1 Oyaguchikamicho, Itabashi, Tokyo, 173-8610, Japan. terui.tadashi@nihon-u.ac.jp.
² Tokyo Medical University, Tokyo, Japan.
³ Seibo International Catholic Hospital, Tokyo, Japan.
⁴ Kochi Medical School, Kochi University, Kochi, Japan.
⁵ Nagoya City University, Nagoya, Japan.
⁶ Fukuoka University, Fukuoka, Japan.
⁷ Teikyo University, Tokyo, Japan.
⁸ Sapporo Skin Clinic, Sapporo, Japan.
⁹ Amgen K.K., Tokyo, Japan.
¹⁰ Amgen Inc., Thousand Oaks, CA, USA.
¹¹ Ehime University Graduate School of Medicine, Ehime, Japan.

No abstract available

Erratum for

Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M. Terui T, et al. Am J Clin Dermatol. 2023 Sep;24(5):837-847. doi: 10.1007/s40257-023-00788-2. Epub 2023 May 26. Am J Clin Dermatol. 2023. PMID: 37233897 Free PMC article. Clinical Trial.